...intense research, the maker of anti-osteoporosis drug Evista is asking the FDA to approve its... Read more »
...make changes in their treatment of osteoporosis. Evista is commonly referred to as a... Read more »
...osteoporosis, too. My doctor has recommended I take Evista, which she said would help on both... Read more »
...after paying a fine for the illegal promotion of Evista as a breast cancer prevention drug,... Read more »
...indicates that raloxifene (sold under the brand name Evista) is safe and effective for treating... Read more »
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »
This is a study to compare the effects of arzoxifene to Evista on bone mineral density in women with osteoporosis. This international study is... Read summary »
A Food and Drug Administration (FDA) panel has recommended Evista for use in preventing breast cancer. Evista is an osteoporosis medication that has... Read summary »
This is a study to determine whether the osteoporosis med Evista improves cognitive function in women with Alzheimer's disease. This national study... Read summary »
This is a study to compare the effects of Zometa and Evista in reducing bone turnover markers in postmenopausal women who have low bone mineral... Read summary »
The U.S. Food and Drug Administration has granted tentative approval for a generic form of the commonly used osteoporosis drug Evista. However, the... Read summary »